Is This the Most Dangerous Health Care Dividend?

Before you go, we thought you'd like these...
Before you go close icon

When looking for large health care dividends, investors are primarily limited to large pharma stocks. However, there are a few exceptions, including a brand new dividend payer in Questcor Pharmaceuticals (NAS: QCOR) . Questcor isn't your run-of-the-mill defensive health care stock -- shares are dealing with multiple headwinds that could impact the sustainability of this payout in the long term.

In the following video, health care bureau chief Brenton Flynn outlines these headwinds, as well as his opinion on what type of investor should be looking to buy Questcor relative to a more stable big pharma dividend stock like Pfizer or Johnson & Johnson.


While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.

The article Is This the Most Dangerous Health Care Dividend? originally appeared on Fool.com.

Brenton Flynn has no positions in the stocks mentioned above. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners